FERRING PHARMACEUTICALS INC. v. PAR PHARMACEUTICAL, INC. [RULE 36 JUDGMENT] 6-6-2018, No. 17-2399 (Fed. Cir. 2018)

Annotate this Case

Download PDF

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ FERRING PHARMACEUTICALS INC., FERRING INTERNATIONAL CENTER SA, Plaintiffs-Appellees v. PAR PHARMACEUTICAL, INC., Defendant-Appellant ______________________ 2017-2399 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:15-cv-00173-RGA, Judge Richard G. Andrews. ______________________ JUDGMENT ______________________ MARY W. BOURKE, Womble Bond Dickinson (US) LLP, Wilmington, DE, argued for plaintiffs-appellees. Also represented by DANIEL M. ATTAWAY, DANA KATHRYN SEVERANCE; JOHN W. COX, Atlanta, GA. RICHARD J. BERMAN, Arent Fox, LLP, Washington, DC, argued for defendant-appellant. Also represented by TANIEL ERMANO ANDERSON, JANINE A. CARLAN. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (REYNA, SCHALL, and STOLL, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT June 8, 2018 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.